$KVUE News

Is Kenvue (KVUE) Below Fair Value After Its 40% Run?

What to Expect From Kenvue's Next Quarterly Earnings Report

Kimberly-Clark’s (KMB) Kenvue (KVUE) Deal Has Jim Cramer Looking Years Ahead

Kenvue (KVUE) Stock Still Appears 41% Undervalued On Cash Flow

Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair

Kenvue Inc's Dividend Analysis

Kimberly Clark (KMB) Lines Up Assets for $40 Billion Deal Review

Should Kenvue’s (KVUE) TYLENOL with Naproxen Launch and Dividend Plan Prompt Investor Reassessment?

Is Kenvue (KVUE) A Bargain Following Its TYLENOL With Naproxen Launch?

Sorbent to acquire Kenvue's Stayfree and Carefree business in Australia and New Zealand

Kenvue Declares Quarterly Cash Dividend

National Advertising Division Finds Hims & Hers Has Support for Combination Efficacy Message; Recommends Modification or Discontinuance of Other Claims

Kenvue (KVUE) Stock Looks Cheap On Cash Flow But Fair On Earnings

Should Zyrtec’s New Drug-Free Allergen Shield Spray Launch Require Action From Kenvue (KVUE) Investors?

Will a Neutrogena boycott by Hayden Panettiere's fans work?

Kenvue (KVUE) Launches Zyrtec Spray As Its Undervalued Case Faces A Fresh Test

Essity acquires feminine care business in Brazil

Essity Strikes Agreement To Acquire Kenvue's Feminine Care Operations In Brazil For $284M

Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects

UBS Maintains Neutral on Kenvue, Lowers Price Target to $19